Skip to main content
Log in

An Addition to Geographic Hematology: Chronic Myeloproliferative Diseases Are Infrequent in Mexican Mestizos

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Background. The chronic myeloproliferative diseases (CMPDs) include chronic myelogenous leukemia (CML), primary (essential) thrombocythemia (PT), agnogenic myeloid metaplasia (AMM), and polycythemia vera (PV). Certain hematological malignancies have a different prevalence in our country than in countries with Caucasian populations. Data indicate that the prevalence of CML in our country is similar to that found in Caucasians; however, the prevalence of the other CMPDs has not been studied.

Methods. In a total of 8069 individuals studied between June 1983 and March 2001 in the Centro de Hematologia y Medicina Interna de Puebla, we assessed the prevalence of CML, PT, AMM, and PV. Some of the clinical features of these individuals were also assessed.

Results and Conclusions. Forty-nine patients with CML, 14 with PT, 7 with AMM, and 3 with PV were identified. The clinical presentations of these CMPDs were not different from those described in Caucasians.

Conclusions.We found that CML was more than 3 times more frequent than PT, that both PV and AMM were exceptional, and that PT, AMM, and PV were significantly less frequent in Mexican than in Caucasian populations (P < .01).Int J Hematol. 2002;75:499–502.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tefferi A. Chronic myeloid disorders: classification and treatment overview.Semin Hematol. 2001;38(suppl 2):1–4.

    Article  CAS  PubMed  Google Scholar 

  2. Messinezy M, Pearson TC. Polycythaemia, primary (essential) thrombocythaemia and myelofibrosis.Br Med J. 1997;314:587–590.

    Article  CAS  Google Scholar 

  3. Labardini-Méndez J. Chronic myeloproliferative disorders. In: Ruiz-Argüelles GJ, ed.Fundamentos de Hematologia.2nd ed. México City: Editorial Médica Panamericana; 1998:209–222.

    Google Scholar 

  4. Murphy S. Diagnostic criteriae and prognosis in polycythemia vera and essential thrombocythemia.Semin Hematol. 1999; 36(suppl 2):9–15.

    CAS  PubMed  Google Scholar 

  5. Messinezy M, Westwood N, Sawyer B, et al. Primary thrombo-cythaemia: a composite approach to diagnosis.Clin Lab Haematol. 1994;16:139–148.

    Article  CAS  PubMed  Google Scholar 

  6. Arends T, Arends A. Introducción a la hematología geográfica. In: López-Borrasca A, Arocha-Piñango CL, Campos-Guerra C, et al, eds.Enciclopedia Iberoamericana de Hematología. Salamanca, Spain: Ediciones Universidad de Salamanca. 1992;IV:601–602.

    Google Scholar 

  7. Lisker R, Ramírez E, Pérez-Briceño R, Granados J, Babinsky V. Gene frequencies and admixture estimates in four Mexican urban centers.Hum Biol. 1990;62:791–794.

    CAS  PubMed  Google Scholar 

  8. Ruiz-Argüelles GJ. Promyelocytic leukaemia in Mexican mestizos.Blood. 1997;89:348–349.

    PubMed  Google Scholar 

  9. Ruiz-Argüelles GJ, Lobato-Mendizábal E, San-Miguel JF, et al. Long-term treatment results for megakaryoblastic leukaemia patients: a multicentre study.Br J Haematol. 1992;82:671–675.

    Article  PubMed  Google Scholar 

  10. Lobato-Mendizábal E, Ruiz-Argüelles GJ. Prevalencia y características de la leucemia linfoblástica de células pre-B en México.Sangre. 1991;36:1–5.

    PubMed  Google Scholar 

  11. Ruiz-Argüelles GJ, Cantú-Rodríguez OG, Gómez-Almaguer D, et al. Hairy cell leukemia is infrequent in México and has a geographic distribution.Am J Hematol. 1996;52:316–318.

    Article  PubMed  Google Scholar 

  12. Alemán-Hoey DD, Ruiz-Argüelles GJ, Verduzco-Rodriguez L, López-Ariza B, Labardini JR. Leucemia linfocítica crónica, I: experiencia de 35 años en el Instituto Nacional de la Nutrición Salvador Zubirán.Rev Invest Clín Méx. 1982;34:151–156.

    Google Scholar 

  13. Ruiz-Argüelles GJ, Velázquez BM, Apreza-Molina MG, Pérez-Romano B, Ruiz-Reyes G, Ruiz-Argüelles A. Chronic lymphocytic leukemia is infrequent in Mexican Mestizos.Int J Hematol.1999;69: 253–255.

    PubMed  Google Scholar 

  14. Ruiz-Argüelles GJ, Cantú-Rodriguez OG, Mercado-Díaz L, et al. Some chronic lymphoproliferative malignancies in México are less frequent than in Caucasian populations.Blood. 1996; 88(suppl 1):217b.

    Google Scholar 

  15. Ruiz-Argüelles GJ, Ramírez-Cisneros FJ, Flores-Martínez J, Cernuda-Graham MC. Waldenström’s macroglobulinemia is infrequent in Mexican Mestizos: experience of a hematological diseases referral center.Rev Invest Clín Méx. 2000;52:497–499.

    Google Scholar 

  16. Ruiz-Argüelles GJ, López-Martínez B, Ramírez-Cabrera JM, Reyes-Nuñez V, Rodríguez-Cedeño H, Garcés-Eisele J. Molecular monitoring of the treatment of patients with BCR/ABL (+) chronic myelogenous leukemia.Rev Invest Clín Méx. 2001;53: 235–239.

    Google Scholar 

  17. Velázquez-Hernández BM, Ruiz-Argüelles GJ, Apreza-Molina MG. Resultados a largo plazo del tratamiento de pacientes con leucemia granulocítica crónica con busulfán y/o hidroxiurea. Estudio prospectivo.Med Int Méx. 1996;12:97.

    Google Scholar 

  18. Mesa RA, Silverstein MV, Jacobsen SJ, Wollan PC, Tefferi A. Population-based incidence and survival figures in essential thrombo-cythemia and agnogenic myeloid metaplasia: an Olmsted County study, 1976–1995.Am J Hematol. 1999;61:10–15.

    Article  CAS  PubMed  Google Scholar 

  19. Kantarjian HM, Talpaz M, Gutterman JU. Chronic myelogenous leukemia: past, present and future.Hematol Pathol. 1988;2:91–120.

    CAS  PubMed  Google Scholar 

  20. Ruiz-Argüelles GJ, Garcés-Eisele J, Reyes-Núñez V, et al. Assessment of residual disease in acute leukemia by means of polymerase chain reaction: a prospective study in a single institution.Rev Invest Clin Mex. 2000;52:118–124.

    Google Scholar 

  21. Ruiz-Argüelles GJ, Ruiz-Delgado GJ, Ruiz-Reyes G, Chernoff SG. Anagrelide-induced relapse of a hydroxyurea-induced leg ulcer in a patient with primary thrombocythemia.Mayo Clin Proc. 1998; 73:1125.

    Article  PubMed  Google Scholar 

  22. Ruiz-Argüelles GJ, Lobato-Mendizábal E, Ruiz-Argüelles A, Pérez-Romano B, Arizpe-Bravo D, Marín-López A. Non-cryopre-served unmanipulated hematopoietic peripheral blood stem cell autotransplant program: long-term results.Arch Med Res. 1999;30: 380–384.

    Article  PubMed  Google Scholar 

  23. Silverstein MN, Tefferi A. Treatment of essential thrombocythemia with anagrelide.Semin Hematol. 1999;36:23–25.

    CAS  PubMed  Google Scholar 

  24. Tefferi A, Silverstein MN, Hoagland HC. Primary thrombo-cythemia.Semin Oncol. 1995;22:334–340.

    CAS  PubMed  Google Scholar 

  25. Ruiz-Argüelles GJ, Marín-López A, Lobato-Mendizábal E, Gamboa-Ojeda I, Sánchez-Anzaldo FJ. El cromosoma Philadelphia lesiona la célula totipotencial: trombocitosis primaria t (9q+; 22q-).Rev Invest Clin Méx. 1984;36:49–51.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guillermo J. Ruiz-Argüelles.

About this article

Cite this article

Ruiz-Argüelles, G.J., López-Martínez, B., Lobato-Mendizábal, E. et al. An Addition to Geographic Hematology: Chronic Myeloproliferative Diseases Are Infrequent in Mexican Mestizos. Int J Hematol 75, 499–502 (2002). https://doi.org/10.1007/BF02982113

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02982113

Key words

Navigation